EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington’s disease

Rachel H Mansky, Erin A Greguske, Dahyun Yu, Nicole Zarate, Taylor A Intihar, Wei Tsai, Taylor G Brown, Mackenzie N Thayer, Kompal Kumar, Rocio Gomez-Pastor

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Rachel H Mansky und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Medical School, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Huntington Disease, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

p53 and HSF1 are two major transcription factors involved in cell proliferation and apoptosis, whose dysregulation contributes to cancer and neurodegeneration. Contrary to most cancers, p53 is increased in Huntington's disease (HD) and other neurodegenerative diseases, while HSF1 is decreased. p53 and HSF1 reciprocal regulation has been shown in different contexts, but their connection in neurodegeneration remains understudied. Using cellular and animal models of HD, we show that mutant HTT stabilized p53 by abrogating the interaction between p53 and E3 ligase MDM2. Stabilized p53 promotes protein kinase CK2 alpha prime and E3 ligase FBXW7 transcription, both of which are responsible for HSF1 degradation. Consequently, p53 deletion in striatal neurons of zQ175 HD mice restores HSF1 abundance and decrease HTT aggregation and striatal pathology. Our work shows the mechanism connecting p53 stabilization with HSF1 degradation and pathophysiology in HD and sheds light on the broader molecular differences and commonalities between cancer and neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseNeoplasmsAnimalsMiceDisease Models, AnimalHeat Shock Transcription FactorsHeat-Shock ResponseProteolysisTumor Suppressor Protein p53Ubiquitin-Protein Ligases

Stichwörter der Autor:innen

CP: Molecular biologyCP: NeuroscienceHSF1Huntington’s diseaseMDM2p53striatal pathology

Substanzen

Heat Shock Transcription FactorsTumor Suppressor Protein p53Ubiquitin-Protein LigasesTrp53 protein, mouseHsf1 protein, mouse

Autor:innen und Institutionen

  • Department of Neuroscience, Medical School, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Neuroscience, Medical School, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: rgomezpa@umn.edu.

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • American Cancer Society

Zitieren

APA

Mansky, R. H., Greguske, E. A., Yu, D., Zarate, N., Intihar, T. A., Tsai, W., Brown, T. G., Thayer, M. N., Kumar, K., & Gomez-Pastor, R. (2023). Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington’s disease. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112198

Vancouver

Mansky RH, Greguske EA, Yu D, Zarate N, Intihar TA, Tsai W, et al. Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington’s disease. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112198

BibTeX
@article{Mansky2023,
  author = {Mansky, Rachel H and Greguske, Erin A and Yu, Dahyun and Zarate, Nicole and Intihar, Taylor A and Tsai, Wei and Brown, Taylor G and Thayer, Mackenzie N and Kumar, Kompal and Gomez-Pastor, Rocio},
  title = {Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington’s disease},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112198}
}
Kostenlos starten →